<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">
<html>&#13;
&#13;
<head>&#13;
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet"/>&#13;
    <link href="./static/css/outliers.css" rel="stylesheet"/>&#13;
    <meta charset="UTF-8"/>&#13;
</head>&#13;
&#13;
<body>&#13;
    <div class="container"><h1>Static outliers for Aylesford Medical Centre</h1>
<p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
    explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to: identify unusual prescribing, collect feedback on this prescribing to inform development of new tools to support
    prescribers and organisations to audit and review prescribing.</p>
<p>The below reports have been developed to use &#8220;z-scores&#8221; to automatically identify prescribing patterns at a chemical level which are furthest away from &#8220;typical prescribing&#8221; and can be classified as an &#8220;outlier&#8221;. It is important to remember that
    this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not. Our full analytical
    method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a> but briefly we calculate the number of prescriptions for each chemical in the BNF coding system using the BNF subparagraph as a denominator.
    We used the time period from 1 April 2021 to 1 August 2021. We then calculate the mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs. From this we can calculate the &#8220;z-score&#8221;, which is a measure
    of how many standard deviations a given practice/CCG/PCN is from the population mean. We then rank your &#8220;z-scores&#8221; to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier
    for prescribing lower than its peers.</p>
<p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&amp;entry.2016356131=practice+G82058">survey</a>
    or emailing us at
    <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed
    feedback.
</p><h2>Prescribing where Aylesford Medical Centre is higher than most</h2>&#13;
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">&#13;
  <thead>&#13;
    &#13;
    &#13;
  <tr><th>BNF Chemical</th>&#13;
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>&#13;
      <th>BNF Subparagraph</th>&#13;
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>&#13;
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>&#13;
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>&#13;
      <th><abbr title="Standard Deviation">std</abbr></th>&#13;
      <th><abbr title="Number of standard deviations prescribeditem count is away from the mean">Z_Score</abbr></th>&#13;
      <th>Plots</th>&#13;
    </tr></thead>&#13;
  &#13;
<tbody><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82058&amp;numIds=1001040K0&amp;denomIds=10.1.4&amp;selectedTab=summary">Probenecid</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>6</td>&#13;
      <td>Gout and cytotoxic induced hyperiuicaemia</td>&#13;
      <td>395</td>&#13;
      <td>0.02</td>&#13;
      <td>0.00</td>&#13;
      <td>0.00</td>&#13;
      <td>18.31</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82058&amp;numIds=1001040K0AAAAAA&amp;denomIds=10.1.4&amp;selectedTab=summary" target="_blank">Probenecid 500mg tablets : 6</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82058&amp;numIds=1304000C0&amp;denomIds=13.4&amp;selectedTab=summary">Beclometasone dipropionate</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>2</td>&#13;
      <td>Topical corticosteroids</td>&#13;
      <td>440</td>&#13;
      <td>0.00</td>&#13;
      <td>0.00</td>&#13;
      <td>0.00</td>&#13;
      <td>5.92</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82058&amp;numIds=1304000C0AACGCG&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Beclometasone 0.0025% in White soft paraffin : 2</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82058&amp;numIds=0304010Y0&amp;denomIds=3.4.1&amp;selectedTab=summary">Alimemazine tartrate</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>32</td>&#13;
      <td>Antihistamines</td>&#13;
      <td>1265</td>&#13;
      <td>0.03</td>&#13;
      <td>0.00</td>&#13;
      <td>0.00</td>&#13;
      <td>5.50</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAFPklEQVR4nO3dXagUdRjH8e9fQj2B9iIqCceGDkXRRRJFaSFRF72sEEg3EkF4oXRt5UDdlF1sdScFvWEhvdBFLxeOkVlpdKH0TmRBQouFhhdl55CveJ4uZg4Np+Nxdvf/zJ7T/D7wZ2f37D7P/OH8dmdnZ3eCmSEizTBn0CsgIvVR4EUaRIEXaRAFXqRBFHiRBlHgRRpEgRdpEAVepEEUeJEGUeBFGkSBl/6EoGOzZ5FogU/SbGOSZutj1ROR+GK+wj8CbIxYT0Qiixn41cAlSZotjVhTRCKKFvhOu3UY+AC4O1ZNEYkr9k67DGhFrikikcQO/F5gVZJmcyPXFZEIoga+026dAr4Abo1ZV0Ti8PgcfgfarBeZkTwCvxO4x6GuiPQpeuCLvfUnkjQbiV1bRPrjdWjtHvQ+XmTG8Qr8fuAmp9oi0iOvwO9DgReZcbwCfwhYkqTZhU71RaQHLoHvtFsGfAVc71FfRHrj+X34/cDNjvVFpEuegdf7eJEZxjPwXwI3OtYXkS65Bb7Tbo0Bo0maLfPqISLd8f5NO30eLzKDeAd+H9pxJzJj6BVepEG8A/8jMJKk2ULnPiJSgWvgO+3WWfLvx9/r2UdEqqnjRBRvAetq6CMi51FH4D8HrknSbHENvURkGu6B77Rb48A7wH3evURkenWdW+5NtFkvMnB1Bf4bYHGSZsM19RORKdQS+OLrsm8DD9TRT0SmVufpol8EHkzSTL9oKzIgtQW+024dIT/v3NYkzW6vq6+I/CuYWa0NkzS7mvwcdNuBj4H9nXbrTK0rIfGEYJiFQa+GVFN74AGSNFsOrAXuAG4AjgG/FuPQ5OVOu3W89pWUahT4WWUggS9L0iwAFwPLgeFilJeHgSHgd+A34DBwpLgsLx8tDuWVOinws8rAA19FkmZzgKXk4b+sGMuKMbG8BAjAGPAXMDrF5ShwHDgBnCwuy2Oq204VBw/JVBT4WWVWBL6q4olhAbAQuOgcl0PFmF9aHprm9vnkTyRWjJP894nhNHC2GOOl5fL18eLx46VRvn6ux08eE+tBF5de97XO02u2JZt3rPeq773+XTymiqr3jXq/Tru1u2I9MLMoA9gQq5Z6qId6+IyYH8ttiFhLPdRDPRzUeeCNiAyYAi/SIDED/1LEWuqhHurh4H+1l15EpqdNepEGuaCbO4cQVgOrgKNmti2EsBYYAQ4CPwD3A38CzwFPFQ97zMwqHwHXRY/XgBeAnWa2PeI8fgHaZnZXCGER8DBwwsyedOqxgnwP7i4zez9ij2PF38aAN5zmUe7xmdM8DgJ3AmeA153mUe6x12MeZvZeCGEdcDnwcq/z6Fe3r/ArzawNTPw+3ZVm9ixwFdAiD/k84DrgI2B3sezRY5w8+L2cg/6cPczsW2BPcfttwCvA4RDCpU49TpMHJvY8PgXawCLHeZR7eM3je/L/0yHHeZR7uMwjhHAt+WHg9DmPvnQb+Mlv+D12AFTqYWajZvYQMC+EsMCjR5+qzuOAmW0GrnDo8Sj5q0k/KvXwnIeZPUN+WHQ/KvVwnMdKYAVwSw91o+lqp12xybIS+AP4mnzzZAT4mfykE+vIX3WfB7YUD3u8h036Kj3eJd+8XwJssi4mcp4e3wFbyTcfdwObyDe9tkxdre8eB4A1wFwzeyJij6Xk30TcBXziNI9yj5+c5vF38bfjwKtO8yj3+NBjHhNvD0IIKfmTcE/z6Jf20os0iPbSizSIAi/SIAq8SIMo8CINosCLNIgCL9IgCrxIgyjwIg2iwIs0iAIv0iAKvEiD/AMn93YN2HBHBwAAAABJRU5ErkJggg=="/></td>&#13;
    </tr>&#13;
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82058&amp;numIds=0304010Y0AAADAD&amp;denomIds=3.4.1&amp;selectedTab=summary" target="_blank">Alimemazine 10mg tablets : 32</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82058&amp;numIds=1001010AJ&amp;denomIds=10.1.1&amp;selectedTab=summary">Etoricoxib</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>96</td>&#13;
      <td>Non-steroidal anti-inflammatory drugs</td>&#13;
      <td>439</td>&#13;
      <td>0.22</td>&#13;
      <td>0.04</td>&#13;
      <td>0.04</td>&#13;
      <td>4.10</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82058&amp;numIds=1001010AJAAAAAA&amp;denomIds=10.1.1&amp;selectedTab=summary" target="_blank">Etoricoxib 60mg tablets : 41</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82058&amp;numIds=1001010AJAAADAD&amp;denomIds=10.1.1&amp;selectedTab=summary" target="_blank">Etoricoxib 30mg tablets : 36</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82058&amp;numIds=1001010AJAAACAC&amp;denomIds=10.1.1&amp;selectedTab=summary" target="_blank">Etoricoxib 120mg tablets : 1</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82058&amp;numIds=1001010AJAAABAB&amp;denomIds=10.1.1&amp;selectedTab=summary" target="_blank">Etoricoxib 90mg tablets : 18</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82058&amp;numIds=0601023AD&amp;denomIds=6.1.2&amp;selectedTab=summary">Metformin hydrochloride/sitagliptin</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>145</td>&#13;
      <td>Other antidiabetic drugs</td>&#13;
      <td>1297</td>&#13;
      <td>0.11</td>&#13;
      <td>0.01</td>&#13;
      <td>0.03</td>&#13;
      <td>3.73</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82058&amp;numIds=0601023ADAAAAAA&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Metformin 1g / Sitagliptin 50mg tablets : 99</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82058&amp;numIds=0601023ADBBAAAA&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Janumet 50mg/1000mg tablets : 46</a></div></td></tr></tbody></table>&#13;
&#13;
        <h2>Prescribing where Aylesford Medical Centre is lower than most</h2>&#13;
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">&#13;
  <thead>&#13;
    &#13;
    &#13;
  <tr><th>BNF Chemical</th>&#13;
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>&#13;
      <th>BNF Subparagraph</th>&#13;
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>&#13;
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>&#13;
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>&#13;
      <th><abbr title="Standard Deviation">std</abbr></th>&#13;
      <th><abbr title="Number of standard deviations prescribeditem count is away from the mean">Z_Score</abbr></th>&#13;
      <th>Plots</th>&#13;
    </tr></thead>&#13;
  &#13;
<tbody><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82058&amp;numIds=130201000&amp;denomIds=13.2.1&amp;selectedTab=summary">Other emollient preparations</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>259</td>&#13;
      <td>Emollients</td>&#13;
      <td>373</td>&#13;
      <td>0.69</td>&#13;
      <td>0.89</td>&#13;
      <td>0.07</td>&#13;
      <td>-2.78</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82058&amp;numIds=130201000BBBAAL&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">E45 cream : 46</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82058&amp;numIds=130201000BBCJA8&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Aveeno cream : 83</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82058&amp;numIds=130201000BBICBW&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Dermol 500 lotion : 50</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82058&amp;numIds=130201000BBAUA0&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">E45 lotion : 1</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82058&amp;numIds=130201000BBJPCD&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Oilatum cream : 1</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82058&amp;numIds=130201000AAA6A6&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">White soft paraffin 50% / Liquid paraffin 50% ointment : 4</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82058&amp;numIds=130201000BBKFA0&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Dermol cream : 13</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82058&amp;numIds=130201000BBJGCA&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Doublebase gel : 22</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82058&amp;numIds=130201000BBKKCD&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Oilatum Junior cream : 3</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82058&amp;numIds=130201000AACACA&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Isopropyl myristate 15% / Liquid paraffin 15% gel : 6</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82058&amp;numIds=130201000BBJMCB&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Aveeno lotion : 20</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82058&amp;numIds=130201000BBKDA0&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Aveeno Skin Relief moisturising lotion with shea butter : 5</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82058&amp;numIds=130201000BBLACA&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Doublebase Dayleve gel : 5</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82058&amp;numIds=1202030S0&amp;denomIds=12.2.3&amp;selectedTab=summary">Neomycin sulfate</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>16</td>&#13;
      <td>Nasal preparations for infection</td>&#13;
      <td>31</td>&#13;
      <td>0.52</td>&#13;
      <td>0.84</td>&#13;
      <td>0.14</td>&#13;
      <td>-2.26</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82058&amp;numIds=1202030S0AAAAAA&amp;denomIds=12.2.3&amp;selectedTab=summary" target="_blank">Neomycin 0.5% / Chlorhexidine hydrochloride 0.1% cream : 9</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82058&amp;numIds=1202030S0BBAAAA&amp;denomIds=12.2.3&amp;selectedTab=summary" target="_blank">Naseptin nasal cream : 7</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82058&amp;numIds=0103010H0&amp;denomIds=1.3.1&amp;selectedTab=summary">Famotidine</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>11</td>&#13;
      <td>H2-Receptor antagonists</td>&#13;
      <td>38</td>&#13;
      <td>0.29</td>&#13;
      <td>0.78</td>&#13;
      <td>0.23</td>&#13;
      <td>-2.10</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82058&amp;numIds=0103010H0AAAAAA&amp;denomIds=1.3.1&amp;selectedTab=summary" target="_blank">Famotidine 20mg tablets : 11</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82058&amp;numIds=0105020A0&amp;denomIds=1.5.2&amp;selectedTab=summary">Budesonide</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>0</td>&#13;
      <td>Corticosteroids</td>&#13;
      <td>3</td>&#13;
      <td>0.00</td>&#13;
      <td>0.70</td>&#13;
      <td>0.34</td>&#13;
      <td>-2.08</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div/></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82058&amp;numIds=1105000B0&amp;denomIds=11.5&amp;selectedTab=summary">Atropine sulfate</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>0</td>&#13;
      <td>Mydriatics and cycloplegics</td>&#13;
      <td>1</td>&#13;
      <td>0.00</td>&#13;
      <td>0.72</td>&#13;
      <td>0.38</td>&#13;
      <td>-1.91</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div/></td></tr></tbody></table>&#13;
&#13;
    </div><script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"/>&#13;
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"/>&#13;
</body>&#13;
&#13;
</html>